Testosterone prescribing in the United States, 2002-2016

Jacques Baillargeon; Yong Fang Kuo; Jordan R. Westra; Randall J. Urban; James S. Goodwin

doi:10.1001/jama.2018.7999

Testosterone prescribing in the United States, 2002-2016

Jacques Baillargeon, Yong Fang Kuo, Jordan R. Westra, Randall J. Urban, James S. Goodwin

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	200-202
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	320
Issue number	2
DOIs	https://doi.org/10.1001/jama.2018.7999
State	Published - Jul 10 2018

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2018.7999

Cite this

@article{b083945d8b5448d38f0c2ce6783fb601,

title = "Testosterone prescribing in the United States, 2002-2016",

author = "Jacques Baillargeon and Kuo, {Yong Fang} and Westra, {Jordan R.} and Urban, {Randall J.} and Goodwin, {James S.}",

note = "Funding Information: Funding/Support: This study was supported by grants UL1TR001439 and P30AG024832 from the National Institutes of Health. Funding Information: Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Baillargeon reported receiving personal fees from AbbVie, Endo Pharmaceuticals, Auxilium Pharmaceuticals, and GlaxoSmithKline. Dr Kuo reported receiving grants from Agency for Healthcare Research and Quality and National Institute on Drug Abuse. No other disclosures were reported.",

year = "2018",

month = jul,

day = "10",

doi = "10.1001/jama.2018.7999",

language = "English (US)",

volume = "320",

pages = "200--202",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - Testosterone prescribing in the United States, 2002-2016

AU - Baillargeon, Jacques

AU - Kuo, Yong Fang

AU - Westra, Jordan R.

AU - Urban, Randall J.

AU - Goodwin, James S.

N1 - Funding Information: Funding/Support: This study was supported by grants UL1TR001439 and P30AG024832 from the National Institutes of Health. Funding Information: Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Baillargeon reported receiving personal fees from AbbVie, Endo Pharmaceuticals, Auxilium Pharmaceuticals, and GlaxoSmithKline. Dr Kuo reported receiving grants from Agency for Healthcare Research and Quality and National Institute on Drug Abuse. No other disclosures were reported.

PY - 2018/7/10

Y1 - 2018/7/10

UR - http://www.scopus.com/inward/record.url?scp=85050160000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050160000&partnerID=8YFLogxK

U2 - 10.1001/jama.2018.7999

DO - 10.1001/jama.2018.7999

M3 - Letter

C2 - 29998328

AN - SCOPUS:85050160000

SN - 0098-7484

VL - 320

SP - 200

EP - 202

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 2

ER -

Testosterone prescribing in the United States, 2002-2016

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this